Craft
  • Home
  •  / Pliant Therapeutics
Pliant Therapeutics

Pliant Therapeutics

Total Funding

$107 M

Pliant Therapeutics Summary

Company summary

Overview
Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, the company aims to prevent or reverse fibrosis to address the needs of patients. It also builds a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery.
Type
Private
Founded
2016
HQ
South San Francisco, CA, US | view all locations
Website
http://pliantrx.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Bernard Coulie

    Bernard Coulie, President and Chief Executive Officer, Board Member

  • Éric Lefebvre

    Éric Lefebvre, Chief Medical Officer

  • Hans Hull

    Hans Hull, Chief Business Officer

  • Katerina Leftheris

    Katerina Leftheris, Vice President, Chemistry

LocationsView all

1 location detected

  • South San Francisco, CA HQ

    United States

    260 Littlefield Ave

Footer menu